Quick Answer
Glucose Health, Inc. reported Total Revenue of $313.2 thousand for fiscal year 2016.
Glucose Health, Inc. — Key Financials by Year
| Metric | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|
| Total Revenue | $313.2K +7232.1% |
$4.3K +56.0% |
$2.7K +1122.8% |
$224.00 | — | — |
| Net Income | -$410.4K -54.3% |
-$266.1K +60.3% |
-$669.4K +54.1% |
-$1.46M -265.6% |
-$399.1K +55.6% |
-$899.2K -42.1% |
| Total Assets | $33.1K +115.1% |
$15.4K -65.0% |
$44.0K +72.1% |
$25.6K -87.7% |
$207.7K -11.1% |
$233.7K +166.2% |
| Cash and Equivalents | $20.5K +899.6% |
$2.1K -57.8% |
$4.9K +585.1% |
$711.00 -33.9% |
$1.1K -72.6% |
$3.9K +11806.1% |
| Stockholders Equity | -$495.4K -27.8% |
-$387.8K -38.2% |
-$280.6K -41.9% |
-$197.8K -990.8% |
$22.2K +107.2% |
-$310.1K +47.8% |
| R&D Expense | — | $48.00 -98.8% |
$4.0K | — | — | — |
| Operating Income | -$86.6K +44.5% |
-$156.2K +71.4% |
-$545.2K +57.0% |
-$1.27M -251.2% |
-$361.4K +59.3% |
-$888.8K -44.6% |
| Gross Profit | $19.2K +4728.0% |
$397.00 +101.9% |
-$20.7K -891.2% |
-$2.1K | — | — |
| Shares Outstanding | 3.31M +35.1% |
2.45M +87.2% |
1.31M +247.0% |
377,456 -96.3% |
10.11M -84.6% |
65.44M +231.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2017 | $23.8K | +1027.2% | -30.1% |
| Net Income | September 30, 2017 | $18.8K | +111.7% | -61.9% |
| Total Assets | September 30, 2017 | $26.4K | -40.1% | -3.5% |
| Cash and Equivalents | September 30, 2017 | $16.6K | — | -9.2% |
| Stockholders Equity | September 30, 2017 | -$426.2K | -14.1% | +5.1% |
| Operating Income | September 30, 2017 | $4.6K | +108.3% | -71.2% |
| Gross Profit | September 30, 2017 | $23.0K | +976.3% | -31.9% |
| Shares Outstanding | September 30, 2017 | 4.52M | +49.1% | +13.5% |
- Glucose Health, Inc. reported Total Revenue of $313.2 thousand for fiscal year 2016.
- Glucose Health, Inc. showed an increase of +7232.1% in Total Revenue compared to the prior fiscal year.
- Glucose Health, Inc. reported Net Income of -$410.4 thousand for fiscal year 2016.
- Glucose Health, Inc. showed a decrease of -54.3% in Net Income compared to the prior fiscal year.
- Glucose Health, Inc. reported Total Assets of $33.1 thousand for fiscal year 2016.
- Glucose Health, Inc. showed an increase of +115.1% in Total Assets compared to the prior fiscal year.
- Glucose Health, Inc. reported Cash and Equivalents of $20.5 thousand for fiscal year 2016.
- Glucose Health, Inc. showed an increase of +899.6% in Cash and Equivalents compared to the prior fiscal year.
- Glucose Health, Inc. reported Stockholders Equity of -$495.4 thousand for fiscal year 2016.
- Glucose Health, Inc. showed a decrease of -27.8% in Stockholders Equity compared to the prior fiscal year.
- Glucose Health, Inc. reported R&D Expense of $48.00 for fiscal year 2015.
- Glucose Health, Inc. showed a decrease of -98.8% in R&D Expense compared to the prior fiscal year.
- Glucose Health, Inc. reported Operating Income of -$86.6 thousand for fiscal year 2016.
- Glucose Health, Inc. showed an increase of +44.5% in Operating Income compared to the prior fiscal year.
- Glucose Health, Inc. reported Gross Profit of $19.2 thousand for fiscal year 2016.
- Glucose Health, Inc. showed an increase of +4728.0% in Gross Profit compared to the prior fiscal year.
- Glucose Health, Inc. reported Shares Outstanding of 3.31 million shares for fiscal year 2016.
- Glucose Health, Inc. showed an increase of +35.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: